Metraipolis › archive › dc_130cec447208

Anti-CD19 CAR T-cell therapy for autoimmune diseases: from exploratory clinical trials to quantitative pharmacodynamic modeling development — Europe PMC PMID:42812715

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42812715
DOI
10.3389/fimmu.2026.1823722
License (as archived)
solo-consultazione
Archived
2026-10-15T15:17:28.692Z
SHA-256 of the archived text
d8cd9c682224c3f0b585d60751a07ec0035b2c57cf910f5d8076d172d501efff
Stable URL of this page
https://metraipolis.com/documento/dc_130cec447208

How to cite

Anti-CD19 CAR T-cell therapy for autoimmune diseases: from exploratory clinical trials to quantitative pharmacodynamic modeling development — Europe PMC PMID:42812715 — Europe PMC (en), https://europepmc.org/article/MED/42812715 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_130cec447208 (Metraipolis archive dc_130cec447208, sha256 d8cd9c682224c3f0b585d60751a07ec0035b2c57cf910f5d8076d172d501efff)
BibTeX
@misc{dc130cec447208,
  title = {Anti-CD19 CAR T-cell therapy for autoimmune diseases: from exploratory clinical trials to quantitative pharmacodynamic modeling development — Europe PMC PMID:42812715},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42812715},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_130cec447208; sha256 d8cd9c682224c3f0b585d60751a07ec0035b2c57cf910f5d8076d172d501efff},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42812715. Agents can read the archived copy with the MCP tool read_document.